Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP30 | Q70CQ3 | 4/20 | 0.38 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.37 |
| ▸ | HSD11B2 | P80365 | 1/20 | 0.37 |
| ▸ | GPR6 | P46095 | 6/20 | 0.35 |
| ▸ | AR | P10275 | 1/20 | 0.33 |
| ▸ | FPR2 | P25090 | 1/20 | 0.33 |
| ▸ | PROKR1 | Q8TCW9 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.31 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2824433 | 0.85 | HSD11B1 (0.40) | HSD11B1HSD11B2MAPK1NPSR1L3MBTL1 | |
| SCHEMBL2824621 | 0.82 | HSD11B1 (0.43) | USP30HSD11B1HSD11B2GPR6SCN9A | |
| SCHEMBL2822224 | 0.81 | HSD11B1 (0.38) | USP30HSD11B1HSD11B2GPR6AR | |
| SCHEMBL2827919 | 0.80 | HSD11B1 (0.40) | USP30HSD11B1HSD11B2GPR6MAPK1 | |
| SCHEMBL2827916 | 0.80 | HSD11B1 (0.40) | USP30HSD11B1HSD11B2GPR6MAPK1 | |
| SCHEMBL2823673 | 0.80 | HSD11B1 (0.44) | USP30HSD11B1HSD11B2GPR6AR | |
| SCHEMBL2827937 | 0.75 | HSD11B1 (0.47) | USP30HSD11B1HSD11B2P2RX7NPC1 | |
| SCHEMBL2827946 | 0.75 | HSD11B1 (0.46) | USP30HSD11B1HSD11B2 | |
| SCHEMBL2823384 | 0.75 | HSD11B1 (0.47) | USP30HSD11B1HSD11B2GPR6P2RX7 | |
| SCHEMBL2823394 | 0.72 | SIGMAR1 (0.38) | HSD11B1HSD11B2GPR6P2RX7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2243479-A2 | Novel amide and amidine derivates and uses thereof | Abbott Laboratories (US) | 2010-10-27 | — | — | EP | claimed |
| US-8507493-B2 | Amide and amidine derivatives and uses thereof | ABBVIE INC. (US) | 2013-08-13 | — | — | US | disclosed |
| EP-2243479-A2 | Novel amide and amidine derivates and uses thereof | Abbott Laboratories (US) | 2010-10-27 | — | — | EP | disclosed |
| US-20100267738-A1 | NOVEL AMIDE AND AMIDINE DERIVATIVES AND USES THEREOF | ABBOTT LABORATORIES (US) | 2010-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100267738-A1 | NOVEL AMIDE AND AMIDINE DERIVATIVES AND USES THEREOF | HSD11B2, HSD11B1, HSD17B2 | USP30 2077/4885HSD11B1 2/4885HSD11B2 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.